Based on 10,000 doses in 6 months and 20,000 in 1 year this gives the initial value of COVID-19 approval of $40 per share, of course based on assumptions:
- $60,000 per treatment (2 doses, $1.2b revenue)
- 10% royalty payment to Osiris (maximum assumed, $120m)
- cost base of 40% ($401m)
- additional business costs of $78m (based on last fy)
- no income tax accounted for (although others have noted msb has around $500m in tax credits so tax would be minimal at least for the first year)
- ($60,000 x 20,000 x 0.9 x 0.4) - $78m = $601.2m/586,586,780 = $1.02 per share x 41 (p/e ratio of csl) = $41.82
- Forums
- ASX - By Stock
- MSB Trading 2020 - a new dawn
Based on 10,000 doses in 6 months and 20,000 in 1 year this...
-
- There are more pages in this discussion • 8,802 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
2 | 5794 | 1.445 |
6 | 50901 | 1.440 |
4 | 52442 | 1.435 |
5 | 177906 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 27045 | 2 |
1.460 | 64331 | 5 |
1.465 | 35901 | 2 |
1.470 | 54504 | 2 |
1.480 | 132521 | 3 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |